Next Article in Journal
Functional Comparison of High and Low Molecular Weight Chitosan on Lipid Metabolism and Signals in High-Fat Diet-Fed Rats
Next Article in Special Issue
Secondary Metabolites and Biological Activity of Invasive Macroalgae of Southern Europe
Previous Article in Journal
Phycochemical Constituents and Biological Activities of Fucus spp.
Previous Article in Special Issue
Computational Methodologies in the Exploration of Marine Natural Product Leads
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessReview
Mar. Drugs 2018, 16(8), 250; https://doi.org/10.3390/md16080250

Potential Role of Seaweed Polyphenols in Cardiovascular-Associated Disorders

1
Department of Pharmacology, School of Pharmacy, University of Granada, 18071 Granada, Spain
2
Instituto de Investigación Biosanitaria de Granada (Ibs.GRANADA), 18071 Granada, Spain
3
CIBER-EHD, Department of Pharmacology, Centre for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain
*
Author to whom correspondence should be addressed.
Received: 29 June 2018 / Revised: 22 July 2018 / Accepted: 26 July 2018 / Published: 28 July 2018
(This article belongs to the Special Issue Progress on Marine Natural Products as Lead Compounds)
Full-Text   |   PDF [3168 KB, uploaded 28 July 2018]   |  

Abstract

The beneficial effects of various polyphenols with plant origins on different cardiovascular-associated disorders, such as hypertension, diabetes mellitus type 2 and metabolic syndrome are well known. Recently, marine crude-drugs are emerging as potential treatments in many noncommunicable conditions, including those involving the cardiovascular system. Among the active compounds responsible for these activities, seaweed polyphenols seem to play a key role. The aim of the present review is to summarise the current knowledge about the beneficial effects reported for edible seaweed polyphenols in the amelioration of these prevalent conditions, focusing on both preclinical and clinical studies. This review will help to establish the basis for future studies in this promising field. View Full-Text
Keywords: cardiovascular diseases; hypertension; immune response; metabolic syndrome; seaweed polyphenols cardiovascular diseases; hypertension; immune response; metabolic syndrome; seaweed polyphenols
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Gómez-Guzmán, M.; Rodríguez-Nogales, A.; Algieri, F.; Gálvez, J. Potential Role of Seaweed Polyphenols in Cardiovascular-Associated Disorders. Mar. Drugs 2018, 16, 250.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top